https://www.selleckchem.com/products/brd3308.html
NBTXR3 remodeled the immune microenvironment of unirradiated tumors by triggering the activation of various immune pathways, increasing the number of CD8 T cells, and modifying the T cell receptor repertoire in the 344SQR tumor model. The ability of NBTXR3 to evoke significant abscopal effects in both anti-PD1-sensitive and anti-PD1-resistant lung cancers could open the possibility of its use for treating patients with metastatic lung cancer regardless of sensitivity (or resistance) to immunotherapies. The ability of NBTXR3 to evoke sig
Like
Comment
Share
